September 06, 2013
In an unusual case that required an interpretation of Ukrainian patent law to determine ownership of U.S. patents, a California federal judge has ruled that Synbias Pharma cannot be sued by Solux Corp. for infringing chemotherapy drug patents because Synbias co-owns them.